Review: taking Victoza and Humalog together


Summary

Drug interactions are reported among people who take Victoza and Humalog together. This review analyzes the effectiveness and drug interactions between Victoza and Humalog. It is created by eHealthMe based on reports of 114 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Victoza and Humalog >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Victoza

Victoza has active ingredients of liraglutide. It is often used in type 2 diabetes. (latest outcomes from Victoza 12,088 users)

Humalog

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. (latest outcomes from Humalog 26,913 users)

On Jul, 20, 2016

114 people who take Victoza, Humalog are studied.


Number of reports submitted per year:

Victoza and Humalog drug interactions.

Drug effectiveness over time:

Victoza:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 66.0% - (2 of 3 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Humalog:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Victoza:
  • female: 50.0% - (1 of 2 people)
  • male: 80.0% - (4 of 5 people)
Humalog:
  • female: 0.0% - (0 of 2 people)
  • male: 80.0% - (4 of 5 people)

Drug effectiveness by age:

Victoza:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 80.0% - (4 of 5 people)
  • 60+: 0.0% - (0 of 0 people)
Humalog:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 80.0% - (4 of 5 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • dehydration
  • diabetic ketoacidosis
  • renal failure
  • vomiting
  • depressed level of consciousness
  • liver disorder
  • pancreatitis acute
  • diarrhoea
  • intestinal obstruction
  • diabetic hyperosmolar coma
1 - 6 months:
  • atrial fibrillation
  • burping
  • chills
  • dehydration
  • dementia
  • diarrhea
  • nausea
  • renal failure
  • vomiting
  • aortic valve incompetence
6 - 12 months:
  • chest pain
  • dysarthria
  • pancreatitis acute
  • aspartate aminotransferase increased
  • blood triglycerides increased
  • blood urine
  • metastases to liver
  • night sweats
  • pancreatic carcinoma stage iv
1 - 2 years:
  • dermatitis infected
2 - 5 years:
  • burping
  • chills
  • dementia
  • diarrhea
  • nausea
  • vomiting
5 - 10 years:
  • erectile dysfunction
10+ years:
  • blood urine
  • night sweats
not specified:
  • nausea
  • blood glucose increased
  • blood glucose decreased
  • vomiting
  • weight decreased
  • decreased appetite
  • renal failure
  • pancreatitis acute
  • depressed level of consciousness
  • myocardial infarction

Most common drug interactions by gender *:

female:
  • nausea
  • blood glucose decreased
  • renal failure
  • blood glucose increased
  • weight decreased
  • decreased appetite
  • dehydration
  • diabetic ketoacidosis
  • fluid retention
  • vomiting
male:
  • vomiting
  • depressed level of consciousness
  • nausea
  • liver disorder
  • blood glucose increased
  • atrial fibrillation
  • frequent bowel movements
  • neck mass
  • pancreatitis acute
  • myocardial infarction

Most common drug interactions by age *:

10-19:
  • fluid retention
  • pancytopenia
  • staphylococcal sepsis
30-39:
  • blood glucose decreased
  • blood glucose increased
  • chest pain
  • gastric disorder
  • insulin resistance
  • lung infection
  • macular degeneration
  • malaise
  • stress
  • visual impairment
40-49:
  • diabetic ketoacidosis
  • frequent bowel movements
  • neck mass
  • rotator cuff syndrome
  • tendon rupture
  • tendonitis
  • blood potassium decreased
  • acute respiratory distress syndrome
  • cardiopulmonary failure
  • erectile dysfunction
50-59:
  • nausea
  • blood glucose increased
  • vomiting
  • decreased appetite
  • coronary artery disease
  • dermatitis infected
  • anaphylactic shock
  • burping
  • chills
  • constipation
60+:
  • nausea
  • renal failure
  • vomiting
  • blood glucose decreased
  • dehydration
  • liver disorder
  • pancreatitis acute
  • weight decreased
  • blood glucose increased
  • depressed level of consciousness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Victoza and Humalog?

Can you answer these questions?

More questions for: Victoza, Humalog

You may be interested in these reviews

More reviews for: Victoza, Humalog

On eHealthMe, Victoza (liraglutide) is often used to treat type 2 diabetes. Humalog (insulin lispro recombinant) is often used to treat diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.